First Session, Forty-fourth Parliament, 70-71 Elizabeth II – 1-2 Charles III, 2021-2022-2023 |
HOUSE OF COMMONS OF CANADA |
An Act to amend the Food and Drugs Act (natural health products)
|
FIRST READING, December 5, 2023
|
Mr. Calkins |
This enactment amends the Food and Drugs Act to provide that natural health products are not therapeutic products within the meaning of that Act and therefore not subject to the same monitoring regime as other drugs.
Available on the House of Commons website at the following address:
www.ourcommons.ca
|
1st Session, 44th Parliament, 70-71 Elizabeth II – 1-2 Charles III, 2021-2022-2023 |
HOUSE OF COMMONS OF CANADA |
BILL C-368 |
An Act to amend the Food and Drugs Act (natural health products) |
His Majesty, by and with the advice and consent of the Senate and House of Commons of Canada, enacts as follows:
R.S., c. F-27
therapeutic product means a drug or device or any combination of drugs and devices, Insertion start but does not include a natural health product within the meaning of the Natural Health Products Regulations Insertion end ; (produit thérapeutique)
Published under authority of the Speaker of the House of Commons
|